Big scoop: health ministers in EU’s pharma powers Germany,France,Italy & Netherlands joined forces to obtain vaccines for the bloc (kinda nascent EU Op Warpspeed) but their leaders forced them to abdicate responsibility to the Commission, which then failed to get enough doses 1/3
This is the letter sent by the healthcare minister to the Commission, drafted in slightly apologetic tone, asking the EU executive to take over vaccine procurement. Result: the EU, pop 450m, is now stuck with mere 200m BioNTech-Pfizer and 80m Moderna jabs by the autumn (at best).
Meanwhile, the new coronavirus variant that has spread from Britain could make obtaining herd immunity more difficult: as many as 80% of the population might need to be immunised to halt the pandemic wsj.com/articles/covid…
Germany and Denmark could follow UK leadership in delaying the second dose of the covid vaccines theguardian.com/world/2021/jan…
On November 11, when it was clear that vaccine by @BioNTech_Group & @pfizer was the market leader, the EU ordered 200m doses, with an option for another 100m. On November 17 the EU ordered 400m from CureVac, a German company that hadn’t even started phase 3 trial. Why?
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Some facts on EU vaccine procurement: 1. The EU only ordered 200m doses from @BioNTech_Group & @pfizer on *November 11,* when it was already behind in the queue (the US ordered on July 22). The EU *refused* an offer to order 500m doses.
2. Despite the BioNTech/Pfizer jab winning the global race, the EU stuck to 200m. On November 17 however it ordered 400m doses from CureVac, German firm that hadn't even started Phase3 trial. Only on *December 29* did the EU order additional 100m, again trailing the US
3. Data indicating that BioNTech/Pfizer were ahead of the pack emerged already in July. On *October 6* the EU regulator EMA started a rolling review based on extremely promising late-stage trial data, which was obviously available to EU officials wsj.com/articles/germa…
The U.S., Canada and U.K. have started vaccinating, but the region where the Pfizer-BioNTech shot was developed is still waiting for it. Europeans are becoming unsettled with the wait as pressure grows on regulators to act fast. With @drewhinshaw wsj.com/articles/europ…
The EU’s chief drug regulator EMA is coming under pressure from some governments to authorize a Covid-19 vaccine designed and produced on EU soil, as the continent struggles to contain a deadly wave of cases ahead of Christmas wsj.com/articles/europ…
At an EU summit last week, at least three heads of government complained that it was becoming politically untenable to explain to their citizens why the U.S. and Canada were administering a Europe-made vaccine ahead of the EU wsj.com/articles/europ…
The Swedish #Covid-19 experiment is over. After a severe second #coronavirus wave - which authorities said won’t happen - the government imposed some mandatory restrictions to curb hospitalisations and deaths. My report via @WSJ wsj.com/articles/long-…
After a surge in Covid-19 infections led to rising hospitalizations and deaths, Sweden has abandoned its attempt—unique among Western nations—to combat the pandemic through voluntary measures alone @WSJwsj.com/articles/long-…
With total Covid-19-related deaths reaching almost 700 per million inhabitants, infections growing exponen-tially and hospital wards filling up, the government had to shift wsj.com/articles/long-…
Pre-Brexit, the U.K. regulator’s massive portfolio of Europe-wide medicine evaluations (about 370). The agency has top staff - ~1,300 to EMA's ~900 - and is able to act much quicker outside the EU committee system. Brexit have it political license, too wsj.com/articles/how-t…
U.K. used emergency powers to authorize drugs on its own, allowing the MHRA to review the drug outside the EU framework even before the end of the Brexit transition period. All other EU members have the same power, but none have declared plans to use it wsj.com/articles/how-t…
The married couple Ugur Sahin and Özlem Türeci, founders of @BioNTech_Group, invented the first #COVID19 vaccine to be authorized in the West. But their jab is a byproduct of 30 years of cancer research. My piece via @WSJ wsj.com/articles/how-a…
In January, days before #coronavirus was first diagnosed in Germany, Ugur Sahin, the CEO of @BioNTech_Group, used this knowledge of mRNA to design the vaccine candidate on his home computer within hours. That jab was now authorized in Britain wsj.com/articles/how-a…
Dr. Sahin was born in Iskenderun on Turkey’s Mediterranean coast in 1965. He moved to Germany four years later when his father was recruited to work at a Ford factory near Cologne as part of a policy to rebuild postwar Germany with foreign labor wsj.com/articles/how-a…
Britain becomes first nation in West to get a coronavirus shot; earliest doses to go to most vulnerable. Via @WSJwsj.com/articles/pfize…
Milestone for #Brexit Britain as it becomes the first western nation - ahead of the US and #EU - to authorise a #coronavirus vaccine. The jabs mainly made in Germany will first be administered in the U.K. this week wsj.com/articles/pfize…